IL95387A0 - Transdermal nitroglycerin patch with penetration enhancers - Google Patents

Transdermal nitroglycerin patch with penetration enhancers

Info

Publication number
IL95387A0
IL95387A0 IL95387A IL9538790A IL95387A0 IL 95387 A0 IL95387 A0 IL 95387A0 IL 95387 A IL95387 A IL 95387A IL 9538790 A IL9538790 A IL 9538790A IL 95387 A0 IL95387 A0 IL 95387A0
Authority
IL
Israel
Prior art keywords
penetration enhancers
nitroglycerin patch
transdermal nitroglycerin
transdermal
patch
Prior art date
Application number
IL95387A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL95387A0 publication Critical patent/IL95387A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL95387A 1989-08-17 1990-08-15 Transdermal nitroglycerin patch with penetration enhancers IL95387A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39511989A 1989-08-17 1989-08-17

Publications (1)

Publication Number Publication Date
IL95387A0 true IL95387A0 (en) 1991-06-30

Family

ID=23561776

Family Applications (1)

Application Number Title Priority Date Filing Date
IL95387A IL95387A0 (en) 1989-08-17 1990-08-15 Transdermal nitroglycerin patch with penetration enhancers

Country Status (11)

Country Link
EP (2) EP0486529A1 (de)
AU (1) AU643230B2 (de)
CA (1) CA2064845A1 (de)
FI (1) FI920630A0 (de)
HU (1) HUT59596A (de)
IE (1) IE902970A1 (de)
IL (1) IL95387A0 (de)
NZ (1) NZ234919A (de)
PT (1) PT95012A (de)
WO (1) WO1991002553A2 (de)
ZA (1) ZA906472B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU653156B2 (en) * 1990-06-14 1994-09-22 Dermamed Transdermal administration to humans and animals
DE4210165A1 (de) * 1991-07-30 1993-02-04 Schering Ag Transdermale therapeutische systeme
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
US6635274B1 (en) * 2000-10-27 2003-10-21 Biochemics, Inc. Solution-based transdermal drug delivery system
JP5820206B2 (ja) 2011-09-13 2015-11-24 日東電工株式会社 経皮吸収促進用組成物および貼付製剤
JP5820207B2 (ja) 2011-09-13 2015-11-24 日東電工株式会社 経皮吸収促進用組成物および貼付製剤
US12201732B2 (en) * 2020-12-23 2025-01-21 Game Changer Patch Co. Transdermal patches for hangover minimization and/or recocery, and/or sleep improvement

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
DE3685895T2 (de) * 1985-02-25 1992-12-24 Univ Rutgers Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen.
AU561608B1 (en) * 1985-11-04 1987-05-14 Paco Research Corp. Transdermal vasoactive delivery
US4764381A (en) * 1985-12-06 1988-08-16 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol
JPH069007B2 (ja) * 1986-04-04 1994-02-02 フアナツク株式会社 複合曲面のｎｃデ−タ作成方法
US4908389A (en) * 1986-08-27 1990-03-13 Warner-Lambert Company Penetration enhancement system
JPS6425717A (en) * 1987-05-08 1989-01-27 Eastman Kodak Co Method and apparatus for preventing organic nitric acid ester resistance
JPH02503672A (ja) * 1987-06-01 1990-11-01 ワーナー‐ランバート・コンパニー 水性の系における浸透促進剤としての脂肪酸およびその短鎖エステル
AU622162B2 (en) * 1988-04-22 1992-04-02 Ciba-Geigy Ag Transdermal monolith systems

Also Published As

Publication number Publication date
NZ234919A (en) 1992-07-28
HU9200459D0 (en) 1992-05-28
FI920630A7 (fi) 1992-02-14
PT95012A (pt) 1991-05-22
HUT59596A (en) 1992-06-29
WO1991002553A3 (en) 1991-04-04
EP0417496A3 (en) 1991-07-03
EP0486529A1 (de) 1992-05-27
FI920630A0 (fi) 1992-02-14
WO1991002553A2 (en) 1991-03-07
AU6141090A (en) 1991-04-03
CA2064845A1 (en) 1991-02-18
ZA906472B (en) 1991-05-29
EP0417496A2 (de) 1991-03-20
AU643230B2 (en) 1993-11-11
IE902970A1 (en) 1991-02-27

Similar Documents

Publication Publication Date Title
ZA885937B (en) Clebopride transdermal patch
EP0325613A4 (de) Eindringungserhöhende mittel zur transdermalen verabreichung systemischer mittel.
PT83934A (en) A transdermal or dermal patch
IL105600A0 (en) Transdermal penetration enhancers
AU4913497A (en) Potent transdermal penetration enhancers
AU8132787A (en) Penetration enhancers for transdermal delivery of systemic agents
AU2777192A (en) Pentadimine transdermal composition and patch
EP0576605A4 (en) Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers
FI905718A7 (fi) Transdermaalinen väline
AU590921B2 (en) Delayed onset transdermal delivery device
AU3592889A (en) Method for enhancing transdermal penetration and compositions useful therein
AU3772989A (en) Penetration enhancers for transdermal delivery of systemic agent
FI910455L (fi) Komposition med foerbaettrad penetration.
AU3740589A (en) Penetration enhancers for transdermal delivery of systemic agents
FI921121A0 (fi) Transdermal doseringsanordning med foerdroejd start.
ZA906472B (en) Transdermal nitroglycerin patch with penetration enhancers
EP0374218A4 (en) Novel transdermal penetration enhancers
FI953532L (fi) Nitroglyserolia sisältävä laastari, menetelmä sen valmistamiseksi ja sen käyttö
CS427889A3 (en) Transdermal penetration accelerator
JPS5433240A (en) Aluminummdiffused and penetrated steel material
EP0325616A4 (de) Durchdringungserhöhende mittel für transdermale verabreichung systemischer mittel.
FI870557A7 (fi) Dermaaliset ja transdermaaliset laastarit.
AU8132487A (en) Penetration enhancers for transdermal delivery of systemic agents
IE882483L (en) Clebopride transdermal patch
GB8727494D0 (en) Transdermal patch